Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.843 | 1.38e-15 | 4.43e-04 | 3.18e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
MED19 | 219541 | 30 | -2.657 | 3.449 | 115 | Yes | - |
[ NUP88 ] | 4927 | 1 | -1.654 | 2.843 | 19 | - | - |
NCBP1 | 4686 | 6 | -2.510 | 3.149 | 40 | Yes | Yes |
MCRS1 | 10445 | 14 | -2.660 | 3.079 | 63 | Yes | Yes |
LUC7L3 | 51747 | 33 | -3.523 | 3.449 | 18 | Yes | - |
MED28 | 80306 | 16 | -2.404 | 3.216 | 80 | Yes | - |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
NXF1 | 10482 | 10 | -2.426 | 3.538 | 65 | Yes | Yes |
MED12 | 9968 | 14 | -2.465 | 3.206 | 65 | Yes | - |
MED17 | 9440 | 2 | -2.161 | 2.860 | 51 | Yes | - |
NFRKB | 4798 | 48 | -3.129 | 3.108 | 23 | Yes | Yes |
SRSF3 | 6428 | 73 | -2.992 | 3.538 | 54 | Yes | - |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
MED4 | 29079 | 2 | -1.785 | 2.860 | 44 | - | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
NFRKB | 4798 | MCRS1 | 10445 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid |
SRSF3 | 6428 | NXF1 | 10482 | pp | -- | int.I2D: MINT, HPRD; int.Mint: MI:0407(direct interaction), MI:0915(physical association) |
MCRS1 | 10445 | MED4 | 29079 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, HPRD, MINT, VidalHuman_core, IntAct; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
NFRKB | 4798 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
LUC7L3 | 51747 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
MED12 | 9968 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
MED12 | 9968 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
MED17 | 9440 | MED12 | 9968 | pp | -- | int.I2D: BioGrid |
NCBP1 | 4686 | NXF1 | 10482 | pp | -- | int.Mint: MI:0914(association) |
MED17 | 9440 | MED28 | 80306 | pp | -- | int.I2D: BioGrid, BioGrid_Fly, IntAct_Fly |
NUP88 | 4927 | NXF1 | 10482 | pp | -- | int.Intact: MI:0914(association) |
YAP1 | 10413 | MED28 | 80306 | pp | -- | int.I2D: MINT; int.Mint: MI:0915(physical association) |
SRSF3 | 6428 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
HNRNPU | 3192 | NXF1 | 10482 | pp | -- | int.Intact: MI:0914(association) |
MED17 | 9440 | MED4 | 29079 | pp | -- | int.I2D: IntAct_Fly |
NUP88 | 4927 | MED4 | 29079 | pp | -- | int.I2D: BioGrid_Fly, BIND_Fly, FlyLow, IntAct_Fly, MINT_Fly |
MED17 | 9440 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct, BIND, HPRD; int.HPRD: in vitro |
MED12 | 9968 | MED4 | 29079 | pp | -- | int.I2D: BioGrid, MINT; int.Mint: MI:0915(physical association), MI:0914(association) |
MED28 | 80306 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
MED4 | 29079 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
MED4 | 29079 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0016592 | mediator complex | 1.84e-10 | 2.66e-06 | 7.102 | 5 | 10 | 35 |
GO:0005654 | nucleoplasm | 1.15e-08 | 1.66e-04 | 3.152 | 10 | 64 | 1082 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 3.04e-08 | 4.39e-04 | 6.865 | 4 | 8 | 33 |
GO:0010467 | gene expression | 9.90e-08 | 1.43e-03 | 3.523 | 8 | 45 | 669 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 3.29e-07 | 4.75e-03 | 7.687 | 3 | 6 | 14 |
GO:0042809 | vitamin D receptor binding | 4.11e-07 | 5.93e-03 | 7.587 | 3 | 6 | 15 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.32e-06 | 3.35e-02 | 3.783 | 6 | 30 | 419 |
GO:0046966 | thyroid hormone receptor binding | 2.33e-06 | 3.36e-02 | 6.794 | 3 | 6 | 26 |
GO:0030521 | androgen receptor signaling pathway | 9.47e-06 | 1.37e-01 | 6.137 | 3 | 5 | 41 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 1.10e-05 | 1.58e-01 | 6.068 | 3 | 7 | 43 |
GO:0003712 | transcription cofactor activity | 1.17e-05 | 1.69e-01 | 6.035 | 3 | 8 | 44 |
GO:0019827 | stem cell maintenance | 1.44e-05 | 2.07e-01 | 5.940 | 3 | 7 | 47 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 3.14e-05 | 4.52e-01 | 4.386 | 4 | 22 | 184 |
GO:0006406 | mRNA export from nucleus | 3.16e-05 | 4.56e-01 | 5.563 | 3 | 4 | 61 |
GO:0008380 | RNA splicing | 7.24e-05 | 1.00e+00 | 4.076 | 4 | 22 | 228 |
GO:0031011 | Ino80 complex | 9.12e-05 | 1.00e+00 | 7.102 | 2 | 6 | 14 |
GO:0005634 | nucleus | 1.60e-04 | 1.00e+00 | 1.340 | 12 | 159 | 4559 |
GO:0044822 | poly(A) RNA binding | 4.27e-04 | 1.00e+00 | 2.450 | 6 | 50 | 1056 |
GO:0000398 | mRNA splicing, via spliceosome | 5.94e-04 | 1.00e+00 | 4.137 | 3 | 15 | 164 |
GO:0016607 | nuclear speck | 6.82e-04 | 1.00e+00 | 4.068 | 3 | 12 | 172 |
GO:0031124 | mRNA 3'-end processing | 8.49e-04 | 1.00e+00 | 5.517 | 2 | 2 | 42 |
GO:0004872 | receptor activity | 8.97e-04 | 1.00e+00 | 3.932 | 3 | 8 | 189 |
GO:0006369 | termination of RNA polymerase II transcription | 9.74e-04 | 1.00e+00 | 5.417 | 2 | 2 | 45 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0005643 | nuclear pore | 1.56e-03 | 1.00e+00 | 5.076 | 2 | 11 | 57 |
GO:0003713 | transcription coactivator activity | 1.72e-03 | 1.00e+00 | 3.605 | 3 | 24 | 237 |
GO:0006310 | DNA recombination | 2.02e-03 | 1.00e+00 | 4.887 | 2 | 7 | 65 |
GO:0060242 | contact inhibition | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.34e-03 | 1.00e+00 | 3.450 | 3 | 23 | 264 |
GO:0003729 | mRNA binding | 2.47e-03 | 1.00e+00 | 4.739 | 2 | 4 | 72 |
GO:0006355 | regulation of transcription, DNA-templated | 2.61e-03 | 1.00e+00 | 2.270 | 5 | 43 | 997 |
GO:0005515 | protein binding | 2.98e-03 | 1.00e+00 | 0.938 | 12 | 198 | 6024 |
GO:0060913 | cardiac cell fate determination | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 3 |
GO:0090245 | axis elongation involved in somitogenesis | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 3 |
GO:0014044 | Schwann cell development | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 4 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 4 |
GO:0005730 | nucleolus | 4.33e-03 | 1.00e+00 | 1.814 | 6 | 66 | 1641 |
GO:0003723 | RNA binding | 4.86e-03 | 1.00e+00 | 3.076 | 3 | 18 | 342 |
GO:0001714 | endodermal cell fate specification | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 5 |
GO:0045292 | mRNA cis splicing, via spliceosome | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 2 | 5 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 5 |
GO:0030529 | ribonucleoprotein complex | 5.87e-03 | 1.00e+00 | 4.102 | 2 | 5 | 112 |
GO:0070937 | CRD-mediated mRNA stability complex | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 3 | 6 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 8 |
GO:0000339 | RNA cap binding | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 8 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 5 | 9 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 5 | 9 |
GO:0042405 | nuclear inclusion body | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 2 | 9 |
GO:0006379 | mRNA cleavage | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 1 | 9 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 5 | 9 |
GO:0035413 | positive regulation of catenin import into nucleus | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 2 | 10 |
GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 10 |
GO:0005845 | mRNA cap binding complex | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 4 | 11 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.22e-02 | 1.00e+00 | 2.593 | 3 | 24 | 478 |
GO:0008334 | histone mRNA metabolic process | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 12 |
GO:0044212 | transcription regulatory region DNA binding | 1.28e-02 | 1.00e+00 | 3.517 | 2 | 17 | 168 |
GO:0071480 | cellular response to gamma radiation | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 13 |
GO:0000346 | transcription export complex | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 13 |
GO:0005667 | transcription factor complex | 1.39e-02 | 1.00e+00 | 3.458 | 2 | 17 | 175 |
GO:0005685 | U1 snRNP | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 14 |
GO:0005487 | nucleocytoplasmic transporter activity | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 3 | 14 |
GO:0043981 | histone H4-K5 acetylation | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 5 | 15 |
GO:0001824 | blastocyst development | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 2 | 15 |
GO:0043982 | histone H4-K8 acetylation | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 5 | 15 |
GO:0006376 | mRNA splice site selection | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 1 | 15 |
GO:0043274 | phospholipase binding | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 16 |
GO:0001190 | RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 2 | 16 |
GO:0016032 | viral process | 1.65e-02 | 1.00e+00 | 2.433 | 3 | 26 | 534 |
GO:0043984 | histone H4-K16 acetylation | 1.96e-02 | 1.00e+00 | 5.661 | 1 | 5 | 19 |
GO:0014003 | oligodendrocyte development | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 5 | 20 |
GO:0000123 | histone acetyltransferase complex | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 6 | 21 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.26e-02 | 1.00e+00 | 5.450 | 1 | 2 | 22 |
GO:0016020 | membrane | 2.36e-02 | 1.00e+00 | 1.516 | 5 | 46 | 1681 |
GO:0030864 | cortical actin cytoskeleton | 2.37e-02 | 1.00e+00 | 5.386 | 1 | 1 | 23 |
GO:0034660 | ncRNA metabolic process | 2.37e-02 | 1.00e+00 | 5.386 | 1 | 1 | 23 |
GO:0031047 | gene silencing by RNA | 2.57e-02 | 1.00e+00 | 5.265 | 1 | 2 | 25 |
GO:0035329 | hippo signaling | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 5 | 26 |
GO:0000387 | spliceosomal snRNP assembly | 2.77e-02 | 1.00e+00 | 5.154 | 1 | 2 | 27 |
GO:0071339 | MLL1 complex | 2.77e-02 | 1.00e+00 | 5.154 | 1 | 6 | 27 |
GO:0000166 | nucleotide binding | 2.89e-02 | 1.00e+00 | 2.892 | 2 | 13 | 259 |
GO:0006281 | DNA repair | 2.93e-02 | 1.00e+00 | 2.881 | 2 | 14 | 261 |
GO:0006370 | 7-methylguanosine mRNA capping | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 5 | 30 |
GO:0010827 | regulation of glucose transport | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 4 | 30 |
GO:0003677 | DNA binding | 3.25e-02 | 1.00e+00 | 1.659 | 4 | 49 | 1218 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 32 |
GO:0030178 | negative regulation of Wnt signaling pathway | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 4 | 35 |
GO:0007077 | mitotic nuclear envelope disassembly | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 4 | 36 |
GO:0006446 | regulation of translational initiation | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 4 | 36 |
GO:0008645 | hexose transport | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 4 | 39 |
GO:0035019 | somatic stem cell maintenance | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 6 | 40 |
GO:0050434 | positive regulation of viral transcription | 4.48e-02 | 1.00e+00 | 4.450 | 1 | 5 | 44 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.53e-02 | 1.00e+00 | 1.870 | 3 | 41 | 789 |
GO:0051028 | mRNA transport | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 4 | 52 |
GO:0009611 | response to wounding | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 5 | 52 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 5 | 53 |
GO:0015758 | glucose transport | 5.57e-02 | 1.00e+00 | 4.128 | 1 | 4 | 55 |
GO:0006396 | RNA processing | 5.97e-02 | 1.00e+00 | 4.027 | 1 | 5 | 59 |
GO:0008013 | beta-catenin binding | 6.06e-02 | 1.00e+00 | 4.002 | 1 | 9 | 60 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 6.75e-02 | 1.00e+00 | 3.843 | 1 | 6 | 67 |
GO:0010468 | regulation of gene expression | 6.85e-02 | 1.00e+00 | 3.822 | 1 | 2 | 68 |
GO:0001843 | neural tube closure | 7.43e-02 | 1.00e+00 | 3.700 | 1 | 2 | 74 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 7.43e-02 | 1.00e+00 | 3.700 | 1 | 4 | 74 |
GO:0002020 | protease binding | 7.43e-02 | 1.00e+00 | 3.700 | 1 | 6 | 74 |
GO:0060070 | canonical Wnt signaling pathway | 7.53e-02 | 1.00e+00 | 3.680 | 1 | 4 | 75 |
GO:0071013 | catalytic step 2 spliceosome | 7.82e-02 | 1.00e+00 | 3.624 | 1 | 7 | 78 |
GO:0009653 | anatomical structure morphogenesis | 8.30e-02 | 1.00e+00 | 3.534 | 1 | 2 | 83 |
GO:0006464 | cellular protein modification process | 8.39e-02 | 1.00e+00 | 3.517 | 1 | 4 | 84 |
GO:0001649 | osteoblast differentiation | 9.16e-02 | 1.00e+00 | 3.386 | 1 | 5 | 92 |
GO:0005829 | cytosol | 1.02e-01 | 1.00e+00 | 0.946 | 5 | 86 | 2496 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.12e-01 | 1.00e+00 | 3.076 | 1 | 4 | 114 |
GO:0006325 | chromatin organization | 1.16e-01 | 1.00e+00 | 3.027 | 1 | 12 | 118 |
GO:0005215 | transporter activity | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 3 | 130 |
GO:0007507 | heart development | 1.35e-01 | 1.00e+00 | 2.790 | 1 | 7 | 139 |
GO:0006974 | cellular response to DNA damage stimulus | 1.46e-01 | 1.00e+00 | 2.671 | 1 | 7 | 151 |
GO:0008022 | protein C-terminus binding | 1.55e-01 | 1.00e+00 | 2.578 | 1 | 8 | 161 |
GO:0031625 | ubiquitin protein ligase binding | 1.70e-01 | 1.00e+00 | 2.433 | 1 | 5 | 178 |
GO:0003714 | transcription corepressor activity | 1.70e-01 | 1.00e+00 | 2.433 | 1 | 11 | 178 |
GO:0019904 | protein domain specific binding | 1.71e-01 | 1.00e+00 | 2.425 | 1 | 8 | 179 |
GO:0019221 | cytokine-mediated signaling pathway | 2.07e-01 | 1.00e+00 | 2.121 | 1 | 8 | 221 |
GO:0016071 | mRNA metabolic process | 2.09e-01 | 1.00e+00 | 2.108 | 1 | 8 | 223 |
GO:0008134 | transcription factor binding | 2.24e-01 | 1.00e+00 | 1.990 | 1 | 18 | 242 |
GO:0016070 | RNA metabolic process | 2.28e-01 | 1.00e+00 | 1.961 | 1 | 8 | 247 |
GO:0005975 | carbohydrate metabolic process | 2.33e-01 | 1.00e+00 | 1.926 | 1 | 8 | 253 |
GO:0003779 | actin binding | 2.44e-01 | 1.00e+00 | 1.854 | 1 | 10 | 266 |
GO:0006954 | inflammatory response | 2.53e-01 | 1.00e+00 | 1.795 | 1 | 6 | 277 |
GO:0003682 | chromatin binding | 2.91e-01 | 1.00e+00 | 1.556 | 1 | 19 | 327 |
GO:0008283 | cell proliferation | 2.92e-01 | 1.00e+00 | 1.552 | 1 | 14 | 328 |
GO:0015031 | protein transport | 3.02e-01 | 1.00e+00 | 1.496 | 1 | 11 | 341 |
GO:0043565 | sequence-specific DNA binding | 3.05e-01 | 1.00e+00 | 1.475 | 1 | 11 | 346 |
GO:0005925 | focal adhesion | 3.20e-01 | 1.00e+00 | 1.393 | 1 | 9 | 366 |
GO:0000278 | mitotic cell cycle | 3.38e-01 | 1.00e+00 | 1.298 | 1 | 15 | 391 |
GO:0009986 | cell surface | 3.46e-01 | 1.00e+00 | 1.258 | 1 | 9 | 402 |
GO:0005737 | cytoplasm | 3.51e-01 | 1.00e+00 | 0.352 | 5 | 124 | 3767 |
GO:0055085 | transmembrane transport | 3.68e-01 | 1.00e+00 | 1.144 | 1 | 8 | 435 |
GO:0006351 | transcription, DNA-templated | 4.52e-01 | 1.00e+00 | 0.411 | 2 | 57 | 1446 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 5.26e-01 | 1.00e+00 | 0.460 | 1 | 39 | 699 |
GO:0005739 | mitochondrion | 6.59e-01 | 1.00e+00 | -0.054 | 1 | 23 | 998 |
GO:0044281 | small molecule metabolic process | 7.32e-01 | 1.00e+00 | -0.333 | 1 | 20 | 1211 |
GO:0005524 | ATP binding | 7.57e-01 | 1.00e+00 | -0.433 | 1 | 31 | 1298 |
GO:0005886 | plasma membrane | 7.79e-01 | 1.00e+00 | -0.425 | 2 | 49 | 2582 |